Calcineurin Signaling in Cellular Regulation and Disease

Calcineurin is a calcium-calmodulin-activated serine/threonine phosphatase that orchestrates a myriad of cellular processes by dephosphorylating key substrates, most notably the nuclear factor of activated T-cells (NFAT) family of transcription factors. Upon increases in intracellular Ca2+, calcineurin activation promotes NFAT translocation into the nucleus and drives gene programmes governing T-cell activation, neuronal plasticity, cardiomyocyte hypertrophy and vascular remodelling. Endogenous inhibitors, chiefly the regulator of calcineurin 1 (RCAN1) family, establish negative feedback loops that fine-tune phosphatase activity in diverse cell types. Dysregulation of calcineurin signalling underlies a spectrum of human disorders: overactive calcineurin–NFAT drives pathological cardiac and vascular growth, whereas excessive inhibition compromises immune defence and can contribute to neurodegeneration. Clinically, calcineurin inhibitors form the backbone of immunosuppressive regimens in transplantation, but off-target effects underscore the need for more selective modulation. Recent advances have illuminated tissue-specific roles of calcineurin and its regulators, revealing opportunities to intervene in cardiovascular disease, autoimmune disorders, stroke, cancer and inflammatory syndromes.

Research from Nature Portfolio

Conditional genetic ablation of RCAN1 isoforms in mice has uncovered unexpected roles of calcineurin regulation in vascular integrity. Deletion of individual or combined RCAN1 variants in endothelial or smooth muscle compartments induces medial disorganisation and hypercontractility, predisposing to hypertension-mediated intramural haematoma, aneurysm formation and aortic rupture. Mechanistic studies link RCAN1 loss to enhanced GSK-3β activity and myosin light chain activation, while pharmacological inhibition of Rho-kinase rescues the vascular phenotype. These findings refine understanding of how calcineurin regulators preserve arterial structure and suggest that modulation of downstream kinases may mitigate life-threatening vascular complications.

Calcineurin Signaling in Cellular Regulation and Disease publication trend

The graph below shows the total number of articles in calcineurin signaling in cellular regulation and disease across all publications each year (not limited to Nature Index journals).

Technical terms

Calcineurin: A calcium-calmodulin-activated phosphatase that dephosphorylates proteins such as NFAT.

NFAT (Nuclear Factor of Activated T-cells): A family of transcription factors regulated by calcineurin that control gene expression in immune and non-immune cells.

RCAN1 (Regulator of Calcineurin 1): An endogenous inhibitor of calcineurin that modulates phosphatase activity through feedback mechanisms.

Phosphatase: An enzyme that removes phosphate groups from proteins, altering their activity or localisation.

Isoform: A variant form of a protein arising from differential splicing or promoter usage, often with distinct regulatory properties.

References

1. Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture. Nature Communications (2018).
2. RCAN1-mediated calcineurin inhibition as a target for cancer therapy. Molecular Medicine (2022).
3. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways. PLOS ONE (2018).
4. Vascular Endothelial Growth Factor- and Thrombin-induced Termination Factor, Down Syndrome Critical Region-1, Attenuates Endothelial Cell Proliferation and Angiogenesis* ♦. Journal of Biological Chemistry (2004).